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Abstract Arangeof chronic clinical conditions accompanycar-
diomyocyte energetic dysfunction and constitute independent
risk factors for cardiac arrhythmia. We investigated pro-
arrhythmic and arrhythmic phenotypes in energetically deficient
C57BLmicewithgenetic ablation of themitochondrial promoter
peroxisome proliferator-activated receptor-γ coactivator-1β
(Pgc-1β), a known model of ventricular arrhythmia. Pro-
arrhythmic and cellular action potential (AP) characteristicswere
compared in intactLangendorff-perfusedhearts fromyoung (12–
16 week) and aged (> 52 week), wild-type (WT) and Pgc-1β−/−
mice. Simultaneous electrocardiographic and intracellularmicro-
electrode recordings weremade through successive trains of 100
regular stimuli at progressively incremented heart rates. Aged
Pgc-1β−/− hearts displayed an increased incidence of arrhythmia
compared to other groups. Young and aged Pgc-1β−/− hearts
showed higher incidences of alternans in both AP activation
(maximumAPupshootvelocity(dV/dt)maxandlatency), recovery
(action potential duration (APD90) and resting membrane poten-
tial (RMP) characteristics compared toWT hearts. This was par-
ticularly apparent at lower pacing frequencies. These findings
accompaniedreduced(dV/dt)maxandincreasedAPlatencyvalues
in thePgc-1β−/− hearts. APs observed prior to termination of the
protocol showed lower (dV/dt)max and longer AP latencies, but
indistinguishable APD90 and RMPs in arrhythmic compared to
those in non-arrhythmic hearts. APD restitution analysis showed
thatPgc-1β−/− andWThearts showed similar limiting gradients.
However, Pgc-1β−/− hearts had shortened plateau AP wave-
lengths, particularly in aged Pgc-1β−/− hearts. Pgc-1β−/− hearts
therefore show pro-arrhythmic instabilities attributable to altered
APconductionandactivationrather thanrecoverycharacteristics.
Keywords Peroxisome proliferator-activated receptor-γ
coactivator-1 (PGC-1) . Ventricles . Action potential .
Wavelength . Cardiac conduction . Cardiac arrhythmias
Introduction
Following the successful mechanistic and mathematical de-
scription of the cardiac action potential and its propagation,
cardiac electrophysiology has increasingly focused upon the
physiological mechanisms underlying arrhythmia [19]. The
risk of cardiac rhythm abnormalities accumulates with age.
The prevalence of atrial fibrillation rises from ~ 4% of indi-
viduals aged 60–70 to ~ 20% at > 80 years [54], while the
incidence of sudden cardiac death attributable to ventricular
arrhythmias is eight times higher in 75- than 50-year-old in-
dividuals [8]. Metabolic abnormalities associated with chron-
ic, age-dependent, conditions including obesity, insulin resis-
tance, diabetes mellitus and heart failure also accentuate ar-
rhythmic risk, independently of any ischaemic changes arising
from associated coronary vascular effects [1, 28, 51]. These
situations are accompanied by cardiomyocyte energetic and
therefore, mitochondrial dysfunction, itself an independent
arrhythmic risk factor [2]. Thus, inherited mitochondrial
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disorders such as Kearns-Sayre syndrome predispose to fatal
ventricular arrhythmias [24]. Fibrotic defects of the cardiac
conduction system leading to heart block are similarly age-
related and contribute to age-dependent onsets of inherited
arrhythmic conditions including the Brugada syndrome [22].
The peroxisome proliferator-activated receptor-γ
coactivator-1 (PGC-1) family of transcriptional coactivators
offers a strategic target for studying the electrophysiological
consequences of energetic deficiency. PGC-1 regulates mito-
chondrial mass, function and cellular metabolism [13], upreg-
ulating nuclear and mitochondrial gene expression involved in
fatty acid β-oxidation, the tricarboxylic acid cycle and the
electron transport chain [3]. PGC-1 protein expression and,
correspondingly, mitochondrial activity vary with upstream
cellular energy demand [44]. Metabolic conditions such as
obesity, insulin resistance and type II diabetes as well as ad-
vanced age are associatedwith reduced PGC-1 protein expres-
sion and mitochondrial dysfunction [9, 30, 36].
Much of the biochemical insight into the consequences of
cardiac energetic deficiency [21, 38] derives from studies in
hearts with dysfunctional PGC-1 networks [4, 20]. Pgc-1α−/−
murine hearts show normal baseline contractility, developing
heart failure only with increased afterload [3]. Pgc-1β−/− hearts
similarly show normal baseline cardiac function, but display
compromised heart rate responses with adrenergic stimulation
[29]. Langendorff-perfused Pgc-1β−/− hearts demonstrated pre-
liminary evidence for increased arrhythmogenicity. Their isolated
cardiomyocytes showed diastolic Ca2+ transients,
afterdepolarisation events and altered ion channel expression pat-
terns [17], abnormalities also known to occur with ageing [18].
The combination of normal contractile function with pro-
arrhythmic electrophysiological changes suggests that Pgc-
1β−/− hearts are suitable models to explore the pro-
arrhythmic effects of mitochondrial impairment. Isolated, per-
fused, murine hearts have proved to be useful in the study of
arrhythmic phenotypes and their underlying mechanisms.
They have been particularly important in studies of specific
genetic modifications directed at well-defined, inherited,
monogenic ion channelopathies [19, 22, 25]. The present
study extends these analyses to Pgc-1β−/− hearts through the
analysis of the electrophysiological consequences of energetic
dysfunction. Chronic mitochondrial lesions likely exert cumu-
lative and time-varying phenotypic effects with advancing
age, and so the experiments studied both young and aged,
wild-type (WT) and genetically modified animals.
Methods
Animals
This research has been regulated under the Animals (Scientific
Procedures) Act 1986 Amendment Regulations 2012 following
ethical review by the University of Cambridge Animal Welfare
and Ethical Review Body (AWERB). The experiments also
conformed to the Guide for the Care and Use of Laboratory
Animals, U.S. National Institutes of Health (NIH Publication
No. 85-23, revised 1996).Micewere housed in an animal facility
at 21 °C with 12-h light/dark cycles. Animals were fed sterile
chow (RM3 Maintenance Diet; SDS, Witham, Essex, UK) and
had free access to water, bedding and environmental stimuli.
Mice were sacrificed by cervical dislocation. No recovery, anaes-
thetic or surgical procedures were required. Wild-type (WT)
C57/B6 and Pgc-1β−/− adult mice were bred for the experimen-
tal protocols. Pgc-1β−/− mice were generated as described pre-
viously [17, 29]. Briefly, a triple LoxP targeting vector was used,
containing a floxed neomycin phosphotransferase selectable
marker cassette inserted into intron 3 and a single LoxP site
inserted into intron 5. This resulted in the deletion of exons 4
and 5. The presence of LoxP sites was confirmed in embryonic
stem cells using southern blot analysis. Heterozygous triple LoxP
mice crossed with ROSA26-Cre mice generated heterozygous
Pgc-1β−/− mice, which were further bred to generate homozy-
gous Pgc-1β−/−mice. Mice were bred on a C57/B6 background
to avoid possible strain-related confounds. Experiments were
performed in four experimental groups: young WT (n = 23),
young Pgc-1β−/− (n = 21), aged WT (n = 19) and aged Pgc-
1β−/− (n = 25). All young mice were aged between 12 and
16 weeks and aged mice greater than 52 weeks.
Buffering media
All solutions used were based on Krebs–Henseleit (KH) solu-
tion (mM: NaCl, 119; NaHCO3, 25; KCl, 4.0; KH2PO4, 1.2;
MgCl2, 1.0; CaCl2, 1.8; glucose, 10; and Na-pyruvate, 2.0; pH
adjusted to 7.4 and bubbled with 95% O2/5% CO2 (British
Oxygen Company, Manchester, UK). Chemical agents were
purchased from Sigma-Aldrich (Poole, UK). A modified KH
solution containing KH mixed with 20 μM blebbistatin
(Selleckhem, Suffolk, UK) [10–12, 23] was used for perfusion
to immobilise hearts prior to plain Krebs–Henseleit perfusion.
Whole-heart intracellular microelectrode recordings
Prior to sacrifice, 200 IU of unfractionated heparin (Sigma-
Aldrich, Poole, UK) was administered intraperitoneally.
Animals were then sacrificed and rapid sternectomy and
cardiectomywere performed. All hearts were macroscopically
unremarkable with no obvious abnormalities. Hearts were rap-
idly cannulated and secured as previously described [33, 39,
52] before being mounted on a horizontal Langendorff appa-
ratus that was electrically insulated and incorporated into an
intracellular rig within a Faraday cage, incorporating a light
microscope (objective ×5, eyepiece ×5; W. Watson and Sons
Limited, London, UK), organ bath and custom-built micro-
electrode amplifier and head stage.
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Hearts were mounted in a standard anatomical position to
allow impalement of the left ventricular mass and pacing from
the right ventricle simultaneously. The positioning of the re-
cording and stimulating electrodes was controlled by two pre-
cision micromanipulators (Prior Scientific Instruments,
Cambs., UK), calibrated to permit impalements over the same
region of the myocardium. Stimulating and recording elec-
trodes were positioned at consistent sites against the lateral
surface of the right ventricle and the proximal left ventricle
respectively to avoid confounds of regional differences in ac-
tion potential (AP) characteristics. Accordingly, in any given
experiment, alterations in AP latencies, measured as the time
elapsed between the pacing stimulus and peak of the AP,
reflected alterations in AP conduction velocities. Hearts were
perfused with KH solution (at a constant flow rate of
2.1 ml min−1) for at least 5 min to reach steady state, before
being perfused with KH solution and 20 μM blebbistatin to
minimise motion, before resumption of perfusion with plain
KH solution. Preparations which did not show a regular in-
trinsic rhythmwith a basic cycle length (BCL) of <200ms and
1:1 atrioventricular (AV) conduction for > 10-min post-can-
nulation were not studied further. A conventional sharp 3-M
KCl-filled microelectrode (tip resistance 15–25 MΩ, filled
with 3 M KCL) was pulled by a custom-built microelectrode
puller from a glass pipette (1.2 mmOD, 0.69 mm ID; Harvard
Apparatus) and then inserted into a right-angled microelec-
trode holder (Harvard Apparatus, Kent, UK). This was con-
nected to the headstage of a high-input impedance direct-
current microelectrode amplifier system (University of
Cambridge, Cambridge, UK). Following band-pass filtering
between 0 and 2 kHz and amplification, the signal was passed
through an analogue to digital converter at a sampling fre-
quency of 10 kHz (1401; Cambridge Electronic Design,
Cambs., UK). Successful impalement was indicated by the
abrupt appearance of a resting membrane potential lower than
− 70 mVand regular action potentials of stable waveform. All
measurements of intracellular voltage were made relative to
the bath solution via a reference Ag/AgCl electrode.
Whole-heart electrocardiographic recordings
Electrocardiographic (ECG) recordings of isolated
Langendorff-perfused hearts were obtained simultaneously
with intracellular microelectrode measurements to enable cor-
relations between whole-organ rhythms and intracellular volt-
age changes. Recordings were made using two unipolar ECG
electrodes placed at fixed positions around the heart in the
organ bath, corresponding to the standard three-lead ECG
coordinates. The recorded signals were passed through
headstages for pre-amplification, prior to amplification
(Neurolog NL104 amplifier) and band-pass filtering (between
5 and 500 Hz; NL 125/6 filter; Digitimer, Herts, UK) before
being digitized at a sampling frequency of 10 kHz (1401;
Cambridge Electronic Design).
Pacing protocols
Hearts were stimulated at two times the threshold voltage plus
0.5 mV. Hearts underwent two pacing protocols. A
standardised S1S2 protocol consisted of trains of eight stimuli
delivered 125 ms apart (S1 stimuli) followed by an
extrasystolic (S2) stimulus delivered initially at 90 ms after
the previous S1 stimulus. This pattern of stimulation was re-
peated with the S2-S1 interval decremented by 1 ms for each
successive cycle until failure of capture. Incremental pacing
protocols began at a 130 ms basic cycle length (BCL) before
being decremented by 5 ms for each subsequent cycle of 100
stimulations. This cycle was repeated until the heart showed
entry into 2:1 block or arrhythmia.
Data and statistical analysis
Data was captured with Spike2 software (Cambridge
Electronic Design) and then analysed using a custom-written
program using the python programming language. Alternans
was defined as beat to beat changes in the value of a parameter
such that the direction of the change oscillates for at least ten
successive action potentials. All statistical analysis was carried
out using the R programming language [40] and plots with the
grammar of graphics package [49]. All data is expressed as
mean ± standard error of mean (SEM) and a p value of less
than 0.05 taken to be significant. The different experimental
groups were compared with a two-factor analysis of variance
(ANOVA). F values that were significant for interactive ef-
fects prompted post hoc testing with Tukey honestly signifi-
cant difference testing. If single comparisons were made, a
two-tailed Student’s t test was used to compare significance.
Categorical variables were compared using Fisher’s exact test.
Kaplan-Meier estimates were compared with the log-rank test.
Results
We performed simultaneous electrocardiographic (ECG) whole-
heart recordings and action potential (AP) measurements from
single cardiomyocytes in intact ex vivo Langendorff-perfused
hearts. Each procedure began with a programmed electrical stim-
ulation protocol interposing extrasystolic (S2) stimuli at succes-
sively decremented intervals following trains of eight regular
(S1) stimuli applied at a 125 ms basic cycle length (BCL).
Overall ventricular electrical activity through the S1S2 protocol
was monitored by the ECG recordings. Analysis of these initial
recordings yielded ventricular effective refractory periods
(VERPs) that indicated the extent to which BCLs could be de-
creased in the succeeding experiments. A comparison of VERPs
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in young and aged, WT (57.36 ± 2.06 and 56.3 ± 1.96 ms, re-
spectively) and Pgc-1β−/− (53.99 ± 2.2 and 47.64 ± 1.84 ms,
respectively) hearts demonstrated that Pgc-1β−/− hearts showed
shorter VERPs thanWThearts (56.88 ± 1.42 vs 50.54 ± 1.48ms;
n = 42 vs 46; p < 0.01), without effects of either age or interac-
tions between age and genotype.
Intracellular microelectrode recordings of cardiomyocyte
APs within left ventricular epicardia were then obtained in par-
allel with ECG recordings of isolated Langendorff hearts dur-
ing an incremental pacing protocol. Trains of 100 regular stim-
uli were imposed at BCLs progressively shortened by 5 ms
with each successive stimulus train. These examined for the
presence of arrhythmic activity and alternans in AP parameters
related to their activation or recovery. Figure 1 tracks the prog-
ress of the experiments through the incremental pacing protocol
in all the four groups, using Kaplan-Meier plots of the proba-
bility of hearts showing regular 1:1 evoked activity with de-
creasing BCL. Quantitative analysis was performed for BCLs
up to 55 ms, after which insufficient hearts showed regular 1:1
capture for analysis. The BCLs at which hearts failed to follow
the repetitive pacing and entered 2:1 block reflect their VERP at
that particular pacing rate. A log-rank test demonstrated that the
Kaplan-Meier curves from the different experimental groups
(Fig. 1) showed significant differences from each other
(p < 0.01). VERPs at the termination of the protocol (young
WT, 64.35 ± 2.16 ms; aged WT, 61.84 ± 2.33 ms; young Pgc-
1β−/−, 68.33 ± 1.26ms; agedPgc-1β−/− hearts, 61.0 ± 1.83ms)
were obtained from the BCLs achieved just prior to the onset of
2:1 atrioventricular conduction block.
Age-dependent arrhythmic phenotypes in Pgc-1β−/−
hearts
Figure 2 exemplifies intracellular electrophysiological traces
of normal, arrhythmic and pro-arrhythmic activities from all
the four experimental groups obtained in the course of the
incremental pacing protocol. Figure 2 compares parallel
ECG (i) and intracellular AP recordings (ii) of regular ventric-
ular activity at a BCL of 130 ms from a young WTmouse (a).
Similar simultaneous ECG (i) and intracellular AP recordings
(ii) recordings made it possible to detect ectopic beats (b),
monomorphic ventricular tachycardia (VT) (c) and torsades
de pointes (TdP) (d) in aged Pgc-1β−/− hearts. Under these
experimental conditions, there were no observations of spon-
taneous early or delayed afterdepolarisations. The latter have
been reported in other pro-arrhythmic murine systems where
they have been implicated in arrhythmic triggering [5, 6, 14].
Table 1 quantifies the occurrence of arrhythmic phenomena
in cardiomyocytes from which the intracellular records were
obtained. Aged Pgc-1β−/− hearts showed the highest arrhyth-
mic incidences compared to the remaining groups (p < 0.05).
The latter groups showed similar, reduced, arrhythmic fre-
quencies. Aged Pgc-1β−/− hearts were also the only experi-
mental group that showed ectopic activity, monomorphic VT
and polymorphic VT (Fig. 2b–d). The incidence of arrhyth-
mias in hearts from young Pgc-1β−/− hearts was not distin-
guishable from their WT counterparts.
Figure 3 exemplifies the different forms of alternans in AP
characteristics observed in a typical agedPgc-1β−/− heart with
each panel displaying (from top to bottom) AP waveforms,
AP latencies, the first derivative, dV/dt, of the AP waveform,
APD90 and RMP. This makes it possible to directly visualize
alternans in one or more electrophysiological parameters. The
panels demonstrate the possible combinations of alternans in-
volving activation or recovery parameters. Thus, the alternans
in (a) involves the recovery variable of APD90 alone while (b)
demonstrates alternans in the activation variables of AP laten-
cy and (dV/dt)max alone. In contrast, (c) and (d) exemplify
simultaneous alternans involving both activation and recovery
variables. They include the extreme situations resulting in
alternate APs with higher/lower latencies and therefore
lower/higher (dV/dt)max associated with higher/lower (c) or
lower/higher APD90 (d). The second case (d) would corre-
spond to the most pro-arrhythmic situation. The bottom con-
trol trace shows the (relatively constant) resting potentials
through the alternans phenomena.
Increased frequencies of alternans in Pgc-1β−/− hearts
The presence of alternans in one or more AP characteristics
with variations in BCL is an established marker for the insta-
bil i ty presaging development of arrhythmia (see
Introduction).We first compared the number of beats showing
alternans in maximum AP upstroke rate (dV/dt)max (Fig. 4a),
AP latency (Fig. 4b), AP duration to 90% recovery (APD90)
(Fig. 4c) and resting membrane potential (RMP) (Fig. 4d) in
young and aged, WT and Pgc-1β−/− hearts through the incre-
mental pacing protocol described above. Overall incidences of
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Fig. 1 Kaplan-Meier plot of the proportion of young and aged WT and
Pgc-1β−/− hearts showing regular activity with increasing pacing
frequency with the progressive fall off at higher pacing frequencies
resulting in hearts losing capture and entering either 2:1 conduction
block or arrhythmia
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alternans were obtained for each heart by summing the num-
ber of beats of alternans at each BCL examined. The results
were then compared between the experimental groups. Pgc-
1β−/− hearts showed greater overall incidences of alternans
compared to WT hearts in all the parameters (dV/dt)max, AP
latency, APD90 and RMP. Thus, both young and aged Pgc-
1β−/− hearts displayed an increased tendency to display
alternans (Table 2).
Secondly, in addition to the above effects of genotype
alone, genotype and age exerted interacting effects on the
incidence of AP latency alternans (p < 0.05) and APD90
alternans (p < 0.05). Young WT hearts had the lowest inci-
dences of AP latency alternans (575 ± 51 beats) with progres-
sive increases in this incidence through the series: young Pgc-
1β−/− hearts (785 ± 78 beats), aged WT hearts (790 ± 33
beats) and aged Pgc-1β−/− hearts (923 ± 81 beats), with the
last group showing the greatest amount of AP latency
alternans. Post hoc testing demonstrated significantly more
AP latency alternans in young Pgc-1β−/− hearts compared to
that in youngWT hearts (p < 0.01) and that in aged Pgc-1β−/−
hearts compared to that in young WT hearts (p < 0.001). A
similar pattern emerged in post hoc testing for APD90
alternans: all remaining groups showed significantly more
alternans than young WT hearts (young WT vs young Pgc-
1β−/−, 726 ± 65 vs 1068 ± 53 beats, p < 0.001; young WT vs
aged WT, 726 ± 65 vs 1040 ± 37 beats, p = 0.001; young WT
vs aged Pgc-1β−/−, 726 ± 65 vs 1107 ± 60 beats p < 0.0001).
Alternans at longer BCLs, with longer episodes,
and involving multiple AP parameters in Pgc-1β−/− hearts
Figure 4 also displays the distribution of alternans in each
parameter across different BCLs for each experimental group.
It is apparent that there are greater incidences of alternans at
longer BCLs in Pgc-1β−/− hearts than those in WT hearts.
This suggests that they have a greater tendency to instability
even at lower heart rates. In addition to the absolute burden of
alternans described previously, we quantified the number of
discrete sequences of alternans per protocol, the maximum
20mV
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Fig. 2 a–d Parallel ECG (i) and intracellular AP recordings (ii) of regular activity at a 130 ms BCL in ventricles from heart from young WTmouse (a),
and ectopic beat (b), monomorphic VT (c) and torsades de pointes (TdP) (d) VT in aged Pgc-1β−/− hearts
Table 1 Frequency of arrhythmia in the various experimental groups
Arrhythmic Non-
arrhythmic
Total (n) Percentage
arrhythmic
Young WT 4 19 23 17.4
Aged WT 3 16 19 15.8
Young
Pgc-1β−/−
4 17 21 19.0
Aged Pgc-1β−/− 12* 13 25 48*
*p < 0.05
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duration of alternans as well as the amount of simultaneous
alternans between multiple parameters.
First, there were no distinguishable differences in the num-
ber of discrete episodes of alternans in (dV/dt)max, APD90 or
RMP between young and aged, Pgc-1β−/− and WT hearts. In
contrast, aged Pgc-1β−/− hearts showed a higher number of
discrete runs of AP latency alternans than young WT hearts
(11.0 ± 1.24 vs 7.43 ± 0.58 runs of alternans; p < 0.05).
Secondly, the maximum duration of individual alternans
episodes, whether involving (dV/dt)max, AP latency, APD90
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Fig. 3 Examples of alternans
phenomena comparing records of
AP waveform, AP latency, (dV/
dt), APD90 and RMP respectively
in each panel. In a, alternans
exclusively involves the recovery
variable APD90 while in b, it
involves the activation variables
of AP latency and (dV/dt) alone.
In c and d, there is simultaneous
alternans involving both
activation and recovery variables.
These include situations in which
the alternating action potentials
with higher/lower latencies and
therefore lower/higher (dV/dt)max
show either higher/lower (c) or
lower/higher (d) APD90,
respectively
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activation variables of maximum
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recovery (APD90) (c) and resting
membrane potential (RMP) (d) in
young and aged, WT and Pgc-
1β−/− hearts through the
incremental pacing protocol
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or RMP, was significantly longer in Pgc-1β−/− hearts than that
in WT hearts. The maximum duration of alternans episodes
involving AP latency also showed significant interactive ef-
fects of age and genotype (p < 0.05). Post hoc testing demon-
strated that young Pgc-1β−/− hearts showed longer durations
of AP latency alternans than young WT hearts (683 ± 62 vs
406 ± 50 beats; p < 0.01).
Thirdly, alternans simultaneously involving different AP
characteristics were observed within the same heart. This
could involve situations in which the alternating high/low
AP latencies or reduced/increased (dV/dt)max coincided with
higher/lower APD90 values (Fig. 3c), or in the more pro-
arrhythmic pattern, occurred out of phase with higher/lower
APD90 values (Fig. 3d). Pgc-1β
−/− hearts showed more fre-
quent simultaneous (dV/dt)max and APD90 alternans compared
toWT hearts (72.15 ± 2.22 vs 64.97 ± 3.03% of beats, respec-
tively; p = 0.05), with similar occurrences of both patterns of
alternans. Pgc-1β−/− hearts also showed more frequent simul-
taneous APD90 and AP latency alternans (74.03 ± 2.92 vs
65.11 ± 2.61% of beats; p < 0.05). In this case, a greater
number of beats assumed the more pro-arrhythmic pattern
(697 ± 58 vs 537 ± 43 beats; p < 0.05). The incidence of the
more pro-arrhythmic pattern of alternans was also significant-
ly affected by interactions between age and genotype
(p < 0.05). Post hoc Tukey tests demonstrated that young
Pgc-1β−/− hearts showed higher incidences of simultaneous
alternans than young WT hearts (p = 0.01).
Finally, we quantified the amplitude of alternans where this
occurred, by calculating the mean differences between succes-
sive peak and trough values in each parameter. These findings
contrastingly demonstrated no significant variations between
the groups.
Altered action potential characteristics in young and aged
Pgc-1β−/− hearts
These differences in electrophysiological stability and pro-
arrhythmic tendency were then correlated with differences in
AP activation and recovery characteristics over the range of
BCLs explored. Figure 5 plots the activation variables of (dV/
dt)max (a) and AP latency (b) as well as the recovery variables
of APD90, (c) RMP (d) and diastolic interval, DI, (given by the
time between the action potential peak and the preceding
APD90) (e) against BCL in young and aged, Pgc-1β
−/− and
WT hearts. All data varied monotonically with BCL and so
their overall magnitudes could be compared by the areas be-
neath their curves. Table 3 demonstrates that hearts with the
Pgc-1β−/− genotype have lower (dV/dt)max values and in-
creased AP latencies relative to WT (both p < 0.001).
However, there were no detectable effects of either ageing or
any interaction between genotype and ageing on (dV/dt)max. In
contrast, neither APD90 nor RMPs were influenced by geno-
type alone. However, APD90 was longer in aged Pgc-1β
−/−
hearts than that in young Pgc-1β−/− hearts (p < 0.05), and
RMP greater in aged than young hearts.
Wavelength as the basis for arrhythmic substrate
The findings above demonstrate pro-arrhythmic features in
aged Pgc-1β−/− hearts. Further quantification demonstrated
increased alternans in both young and aged Pgc-1β−/− hearts.
This in turn correlated with altered AP activation characteris-
tics as reflected in (dV/dt)max and AP latency, as opposed to
the recovery characteristics, APD90 and RMP. The following
analyses further tested the hypothesis that activation and not
recovery parameters are the primary determinant of arrhyth-
mia in this system.
First, hearts were stratified by arrhythmic and non-
arrhythmic phenotypes, regardless of genotype or age. AP
parameters observed prior to the onset of either arrhythmia
or entry into 2:1 block were then compared. Arrhythmic hearts
(n = 20) showed lower (dV/dt)max and longer AP latencies
than non-arrhythmic hearts (n = 68) ((dV /d t)max,
67.29 ± 6.85 vs 87.66 ± 3.28 V s−1, p < 0.05; AP latencies
22.25 ± 1.50 vs 18.64 ± 0.88 ms, p < 0.05, respectively).
Diastolic interval (DI90) durations were calculated from the
APD90 time to the next action potential peak; thus, they were
consequently altered as expected from the altered AP rise
times (27.43 ± 1.53 vs 31.54 ± 1.09 ms; p < 0.05). There were
no significant differences between their APD90 (32.75 ± 1.22
and 34.79 ± 0.92 ms) and RMPs (−73.81 ± 1.16 vs
Table 2 Results of ANOVA
comparisons of alternans features
in Pgc-1β−/− and WT hearts.
Values represent number of beats
out of 1600 beats
AP parameter Pgc-1β−/− WT p value
Overall incidences of alternans (beats) (dV/dt)max 872 ± 42 659 ± 41 p < 0.0001
AP latency 928 ± 49 672 ± 35; p < 0.001
APD90 1089 ± 40 868 ± 46 p < 0.001
RMP 852 ± 42 694 ± 44 p = 0.01
Maximum duration of alternans episodes (beats) (dV/dt)max 535 ± 41 404 ± 36 p < 0.05
AP latency 611 ± 46 456 ± 34 p < 0.01
APD90 682 ± 57 509 ± 44 p < 0.05
RMP 417 ± 35 312 ± 32 p < 0.05
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−73.60 ± 0.72 mV). These findings implicate AP activation
rather than recovery parameters in the initiation of arrhythmia.
Secondly, previous reports have correlated alternans char-
acteristics to arrhythmic tendency in both monogenic murine
models as well as in clinical situations. Arrhythmic syndromes
primarily attributed to repolarisation abnormalities, exempli-
fied by the murine Scn5a+/ΔKPQ model, were associated
with alterations in the relationship between APD90 and
VERP with varying DI [33, 35, 41]. In contrast, arrhythmia
attributed to altered conduction in Scn5a+/− hearts was asso-
ciated with altered relationships between active AP wave-
lengths, λ, and BCL [39] or resting wavelength λ0 [34].
Figure 6 illustrates the outcome of analyses testing both as-
sumptions. These demonstrated indistinguishable limiting
slopes in restitution plots of APD90 against DI90 in all the four
experimental groups (Fig. 6a), in opposition to the prediction
from the first hypothesis. We then proceeded to determine λ,
calculated as the product of conduction velocity represented
by 1 / (AP latency) and the corresponding VERP at each BCL.
This was derived by interpolating values from the VERP ob-
tained during the S1S2 protocol at a BCL of 125 ms and from
the VERP obtained from the BCL during incremental pacing
prior to loss of 1:1 stimulus capture. Young and aged WT
hearts showed similar λ-BCL and λ-λ0 plots (Fig. 6b, c).
However, Pgc-1β−/− hearts showed lower plateau λ values
compared to WT hearts, particularly with ageing. This would
be consistent with the relative arrhythmic tendencies in the
four experimental groups reported here. Further strengthening
this hypothesis, the mean wavelengths immediately prior to
termination of the protocol into either arrhythmia or 2:1 block
were significantly different (p = 0.01) at 4.4 ± 0.31 (n = 20) for
arrhythmic versus 5.4 ± 0.20 (n = 68) for non-arrhythmic
hearts.
Discussion
The present study explored pro-arrhythmic phenotypes and
their age-dependence in murine hearts deficient in the key
mitochondrial upregulator, Pgc-1β, previously associated
with metabolic dysfunction. Previous molecular and cellular
studies in murine Pgc-1β−/− cardiomyocytes had confirmed
down- regu la t ion o f genes re l a t ed to ox ida t ive
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phosphorylation, electron transport and the Krebs cycle and
upregulation of genes related to cardiac hypertrophy, hypoxia
and heart failure [17]. Their fluometric studies demonstrated
cellular diastolic Ca2+ transients, some forming Ca2+ waves
producing temporal and spatial Ca2+ heterogeneities.
Conventional patch clamp studies demonstrated positive volt-
age shifts in Ca2+ current inactivation, increased Na+, and
transient and inwardly rectifying K+ currents under conditions
of intracellular Ca2+ buffering. These findings together ac-
companied potentially pro-arrhythmic oscillatory resting po-
tentials, early and delayed afterdepolarisations, and burst ac-
tion potential firing on sustained current injection potentially
related to AP alternans, and ventricular tachycardia [17].Ta
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These findings corroborated specifically for the Pgc-1β−/−
model broader associations between energetic dysfunction
and increased reactive oxygen species production [16], the
latter affecting voltage-dependent Na+ and K+ current [32,
48], sarcolemmal KATP channel function, Na
+ and Ca2+ chan-
nel inactivation, late Na+ current and ryanodine receptor func-
tion [19]. Finally, the accompanying ATP/ADP depletion is
known to open sarcolemmal ATP-sensitive K+ channels
(sarcKATP) [2].
Such changes potentially affect cell-cell coupling [43], AP
conduction [32], repolarisation and refractoriness [48], and
predispose to alternans and Ca2+-mediated pro-arrhythmic
triggering [45]. The present experiments now explore and
quantify the latter electrophysiological, potentially pro-ar-
rhythmic, consequences in isolated perfused intact murine
hearts hitherto employed to explore murine models modelling
specific human monogenic channelopathies. [19]. Utilisation
of intracellular cardiomyocyte recordings in this study made it
possible to determine resting membrane potentials (RMPs),
AP amplitudes, and provided sufficient bandwidth to follow
maximum rates of AP depolarisation (dV/dt)max, measure-
ments not possible with monophasic action potential record-
ings used previously. Additional simultaneous whole-heart
ECG recordings allowed correlation of these cellular findings
with arrhythmic events at the whole-organ level. Finally, use
of additional experimental groups made it possible to assess
and compare effects of ageing on the Pgc-1β−/− and WT
phenotypes.
This study is the first to establish an age-dependent pro-
arrhythmic phenotype in Pgc-1β−/− murine hearts and the
electrophysiological basis for this. The pro-arrhythmic
phenotype shown by aged Pgc-1β−/− hearts parallels epi-
demiological clinical data reporting age-dependent ar-
rhythmic risks in metabolic disease. Early or delayed
afterdepolarisation phenomena, previously implicated in
arrhythmic triggering processes [6, 46], were not observed,
making a dependence of the arrhythmic phenotype on such
triggering events less likely.
Pgc-1β−/− hearts irrespective of age showed an increased
incidence of alternans in AP activation ((dV/dt)max and AP
latency) and recovery (APD90 and RMP) parameters. These
occurred at lower pacing frequencies than in WT hearts, con-
sistent with greater instability in hearts with metabolic com-
promise. Arrhythmic substrate resulting from repolarisation
abnormalities gives restitution plots of APD90 against DI90
with distinct gradient properties from those of WT hearts.
However, the restitution loci in Pgc-1β−/− hearts showed lim-
iting slopes indistinguishable from WT hearts. Instead, Pgc-
1β−/− hearts showed compromised AP activation as reflected
in (dV/dt)max and AP latency, and shorter effective refractory
periods than WT hearts. Furthermore, the onset of arrhythmia
was associated with compromised AP activation but normal
AP recovery.
These findings localise the arrhythmic substrate to defects
in AP activation. Pgc-1β−/− hearts had altered AP wavelength
(λ) properties, determined from the conduction velocity—ef-
fective refractory period product. Young and aged WT hearts
showed similar λ-BCL and λ-λ0 plots whereas young and
aged Pgc-1β−/− hearts showed reduced values of λ through
all BCLs—an effect more marked in the aged Pgc-1β−/−
hearts. This finding is an exact parallel of previous demonstra-
tions of the presence of arrhythmic phenotypes and of pro-
arrhythmic alternans phenomena.
The present observations in Pgc-1β−/− hearts parallel fea-
tures reported in Scn5a+/− and RyR2-P2328S/P2328S cardiac
models for Brugada syndrome and catecholaminergic poly-
morphic ventricular tachycardia, respectively [33–35, 39].
Recent work had similarly attributed arrhythmic substrate in
RyR2-P2328S/P2328S hearts to slowed AP conduction ac-
companying reductions in (dV/dt)max [53] and in Na
+ currents
to extents comparable to those observed in NaV1.5-
haploinsufficient Scn5a+/− hearts [26, 27]. These reductions
in Na+ currents in the RyR2-P2328S/P2328S cardiomyocytes
were attributed to effects of altered Ca2+ homeostasis upon
Nav1.5 expression [39] and/or acutely upon Nav1.5 function
[26 , 27] . RyR2 -P2328S/P2328S and Pgc-1β− /−
cardiomyocytes share abnormal Ca2+ handling phenotypes
[17]. The normal or even enhanced Na+ currents in patch-
clamped Pgc-1β−/− cardiomyocytes [17] are compatible with
acute effects of their altered Ca2+ homeostasis upon mem-
brane excitability in cardiomyocytes in intact tissue [26, 31,
39, 42]. Thus, patch-clampedWTmyocytes also show respec-
tive acutely reduced, or increased, Na+ current and (dV/dt)max,
with increases in, or sequestration of, the pipette [Ca2+] [7].
These effects could reflect Ca2+-Nav1.5 interactions involving
direct Ca2+ Nav1.5 binding at an EF hand motif close to the
Nav1.5 carboxy-terminal [50] or indirect Ca
2+ binding involv-
ing an additional ‘IQ’ domain binding site for Ca2+/CaM in
the Nav1.5 C-terminal region [15, 37, 47]. The present find-
ings thus throw light on possible, more widespread, effects of
altered intracellular Ca2+ homeostasis on AP propagation in
addition to identifying electrophysiological mechanisms un-
derlying the arrhythmic risk associated with metabolic
disturbance.
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